C. ANN MERRIFIELD

Insider Reports History

Signature
/s/ Jason Cavalier, Attorney-in-Fact for C. Ann Merrifield
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by C. ANN MERRIFIELD:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lyra Therapeutics, Inc. Director Restricted Stock Units 32,000 14 May 2025 Direct
Lyra Therapeutics, Inc. Director Stock Option 30,000 13 Jun 2024 Direct
INVIVO THERAPEUTICS HOLDINGS CORP. Director Stock Option (right to buy) 4,200 17 Nov 2022 Direct
Flexion Therapeutics Inc Director Common Stock 0 $8.50 19 Nov 2021 Direct
Flexion Therapeutics Inc Director Stock option (right to buy) 0 19 Nov 2021 Direct

Insider Reports Filed by C. ANN MERRIFIELD

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LYRA Lyra Therapeutics, Inc. 14 May 2025 1 $0 4 Director 16 May 2025, 16:30
LYRA Lyra Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:10
LYRA Lyra Therapeutics, Inc. 30 Jun 2023 1 $0 4 Director 05 Jul 2023, 21:49
/report/000110465922120823-merrifield-c-ann-2022-11-17 INVIVO THERAPEUTICS HOLDINGS CORP. 17 Nov 2022 1 $0 4 Director 21 Nov 2022, 16:02
LYRA Lyra Therapeutics, Inc. 16 Jun 2022 1 $0 4 Director 21 Jun 2022, 16:06
LYRA Lyra Therapeutics, Inc. 10 Jun 2022 1 +$20,200 4 Director 13 Jun 2022, 16:05
LYRA Lyra Therapeutics, Inc. 13 May 2022 2 +$18,486 4 Director 17 May 2022, 17:35
/report/000120919121065720-merrifield-c-ann-2021-11-19 Flexion Therapeutics Inc 19 Nov 2021 9 -$161,500 4 Director 19 Nov 2021, 09:17
/report/000120919121043555-merrifield-c-ann-2021-06-24 Flexion Therapeutics Inc 24 Jun 2021 2 $0 4 Director 28 Jun 2021, 18:40
LYRA Lyra Therapeutics, Inc. 17 Jun 2021 1 +$31,395 4 Director 22 Jun 2021, 16:28
LYRA Lyra Therapeutics, Inc. 26 May 2021 1 $0 4 Director 28 May 2021, 18:24